A versatile ES cell-based melanoma mouse modeling platform
暂无分享,去创建一个
F. Karreth | Xiaonan Xu | Arianna Nenci | Ilah Bok | Koji Nakamura | Jordan Reff | Olga Vera | Neel Jasani | Jose G. Gonzalez | J. Reff
[1] Andrej J. Savol,et al. Prolonged Mek1/2 suppression impairs the developmental potential of embryonic stem cells , 2017, Nature.
[2] John G. Doench,et al. In vivo CRISPR screening identifies Ptpn2 as a cancer immunotherapy target , 2017, Nature.
[3] Teng Han,et al. R-Spondin chromosome rearrangements drive Wnt-dependent tumour initiation and maintenance in the intestine , 2017, Nature Communications.
[4] K. Blenman,et al. UV‐induced somatic mutations elicit a functional T cell response in the YUMMER1.7 mouse melanoma model , 2017, Pigment cell & melanoma research.
[5] G. Merlino,et al. Genetically engineered mouse models of melanoma , 2017, Cancer.
[6] Catherine A. Shang,et al. Whole-genome landscapes of major melanoma subtypes , 2017, Nature.
[7] M. Bosenberg,et al. The YUMM lines: a series of congenic mouse melanoma cell lines with defined genetic alterations , 2016, Pigment cell & melanoma research.
[8] S. Ariyan,et al. Exome sequencing identifies recurrent mutations in NF1 and RASopathy genes in sun-exposed melanomas , 2015, Nature Genetics.
[9] I. Huijbers,et al. Selective resistance to the PARP inhibitor olaparib in a mouse model for BRCA1-deficient metaplastic breast cancer , 2015, Proceedings of the National Academy of Sciences.
[10] Hans Clevers,et al. Apc Restoration Promotes Cellular Differentiation and Reestablishes Crypt Homeostasis in Colorectal Cancer , 2015, Cell.
[11] Hans Clevers,et al. Efficient Intracellular Delivery of Native Proteins , 2015, Cell.
[12] Michael B. Mann,et al. Transposon mutagenesis identifies genetic drivers of BrafV600E melanoma , 2015, Nature Genetics.
[13] Lukas E Dow,et al. Inducible in vivo genome editing with CRISPR/Cas9 , 2015, Nature Biotechnology.
[14] A. Rust,et al. BRAF inhibitor resistance mediated by the AKT pathway in an oncogenic BRAF mouse melanoma model , 2015, Proceedings of the National Academy of Sciences.
[15] N. Bardeesy,et al. mTORC1 activation blocks BrafV600E-induced growth arrest but is insufficient for melanoma formation. , 2015, Cancer cell.
[16] Alexandro E. Trevino,et al. Genome-scale transcriptional activation by an engineered CRISPR-Cas9 complex , 2014, Nature.
[17] David B. Darr,et al. Mutation-specific RAS oncogenicity explains NRAS codon 61 selection in melanoma. , 2014, Cancer discovery.
[18] Hao Yin,et al. CRISPR-mediated direct mutation of cancer genes in the mouse liver , 2014, Nature.
[19] J. Fisher,et al. Multiple murine BRafV600E melanoma cell lines with sensitivity to PLX4032 , 2014, Pigment cell & melanoma research.
[20] S. Lowe,et al. Conditional Reverse Tet-Transactivator Mouse Strains for the Efficient Induction of TRE-Regulated Transgenes in Mice , 2014, PloS one.
[21] N. Dhomen,et al. Ultraviolet radiation accelerates BRAF-driven melanomagenesis by targeting TP53 , 2014, Nature.
[22] I. Huijbers,et al. Rapid target gene validation in complex cancer mouse models using re-derived embryonic stem cells , 2014, EMBO molecular medicine.
[23] Neville E. Sanjana,et al. Genome-Scale CRISPR-Cas9 Knockout Screening in Human Cells , 2014, Science.
[24] S. Lowe,et al. A modular and flexible ESC-based mouse model of pancreatic cancer , 2014, Genes & development.
[25] Christof Fellmann,et al. An optimized microRNA backbone for effective single-copy RNAi. , 2013, Cell reports.
[26] M. McMahon,et al. Differential AKT dependency displayed by mouse models of BRAFV600E-initiated melanoma. , 2013, The Journal of clinical investigation.
[27] A. Sivachenko,et al. A Landscape of Driver Mutations in Melanoma , 2012, Cell.
[28] Matthew J. Davis,et al. Exome sequencing identifies recurrent somatic RAC1 mutations in melanoma , 2012, Nature Genetics.
[29] S. Lowe,et al. Life in the Fast Lane: Mammalian Disease Models in the Genomics Era , 2012, Cell.
[30] T. Fennell,et al. Melanoma genome sequencing reveals frequent PREX2 mutations , 2012, Nature.
[31] Christof Fellmann,et al. A pipeline for the generation of shRNA transgenic mice , 2012, Nature Protocols.
[32] D. Rimm,et al. β-catenin signaling controls metastasis in Braf-activated Pten-deficient melanomas. , 2011, Cancer cell.
[33] P. Pandolfi,et al. In Vivo Identification of Tumor- Suppressive PTEN ceRNAs in an Oncogenic BRAF-Induced Mouse Model of Melanoma , 2011, Cell.
[34] Johannes Zuber,et al. A Rapid and Scalable System for Studying Gene Function in Mice Using Conditional RNA Interference , 2011, Cell.
[35] S. Elledge,et al. Functional identification of optimized RNAi triggers using a massively parallel sensor assay. , 2011, Molecular cell.
[36] Christof Fellmann,et al. Toolkit for evaluating genes required for proliferation and survival using tetracycline-regulated RNAi , 2011, Nature Biotechnology.
[37] L. Chin,et al. Non-germline genetically engineered mouse models for translational cancer research , 2010, Nature Reviews Cancer.
[38] L. Chin,et al. Chimeric mouse tumor models reveal differences in pathway activation between ERBB family– and KRAS-dependent lung adenocarcinomas , 2010, Nature Biotechnology.
[39] Bao-cun Sun,et al. Doxycycline inhibits the adhesion and migration of melanoma cells by inhibiting the expression and phosphorylation of focal adhesion kinase (FAK). , 2009, Cancer letters.
[40] J. Reis-Filho,et al. Oncogenic Braf induces melanocyte senescence and melanoma in mice. , 2009, Cancer cell.
[41] R. DePinho,et al. BRafV600E cooperates with Pten silencing to elicit metastatic melanoma , 2009, Nature Genetics.
[42] B. Doble,et al. The ground state of embryonic stem cell self-renewal , 2008, Nature.
[43] David A. Tuveson,et al. Maximizing mouse cancer models , 2007, Nature Reviews Cancer.
[44] M. Serrano,et al. A new mouse model to explore the initiation, progression, and therapy of BRAFV600E-induced lung tumors. , 2007, Genes & development.
[45] D. Pinkel,et al. Somatic activation of KIT in distinct subtypes of melanoma. , 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[46] L. Chin,et al. Characterization of melanocyte‐specific inducible Cre recombinase transgenic mice , 2006, Genesis.
[47] Rudolf Jaenisch,et al. Efficient method to generate single‐copy transgenic mice by site‐specific integration in embryonic stem cells , 2006, Genesis.
[48] C. Pritchard,et al. Expression of endogenous oncogenic V600EB-raf induces proliferation and developmental defects in mice and transformation of primary fibroblasts. , 2005, Cancer research.
[49] J. Fridlyand,et al. Distinct sets of genetic alterations in melanoma. , 2005, The New England journal of medicine.
[50] M. Groszer,et al. Cre/loxP‐mediated inactivation of the murine Pten tumor suppressor gene , 2002, Genesis.
[51] A. Berns,et al. Loss of p16Ink4a confers susceptibility to metastatic melanoma in mice , 2001, Nature.